Activity of aerosol thiamphenicol glycinate acetylcysteinate in a mouse model of S. pyogenes pneumonia

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 7, 1999, Pages 631-634

  Albini, Enrico ^a   Arena, Emanuele ^a   Belluco, Giuliano ^a   Schioppacassi, Giovanna ^a   Ungheri, Domenico ^a  

^a Zambon Group SpA   (Italy)

Author keywords

CAS 20192 91 0; Pneumonia experimental; Thiamphenicol glycinate acetylcysteinate, aerosol therapy, mouse

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ERYTHROMYCIN; THIAMPHENICOL; THIAMPHENICOL GLYCINATE ACETYLCYSTEINE; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; INHALATIONAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PNEUMONIA; STREPTOCOCCUS PYOGENES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032810130     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300474     Document Type: Article

References (16)

1. Zambon Research Laboratories, Thiamphenicol. Experimental and clinical bases of a new antibiotic. Zambon, Bresso/Italy (1968)
2. Plomp, T. A., The distribution of thiamphenicol in various human tissues and body fluids: some therapeutical and toxicological implications. Thesis, University of Utrecht (1979)
3. Proceedings of the Round Table "Riacutizzazioni infettive in corso di broncopneumopatie croniche. Criteri terapeutici e confronto tra trattamenti antibatterici", XXV Congresso Italiano Tisiologia e Malattie Polmonary Sociali, Napoli, (Italy), October 22-25, 1980. Med. Torac. 2 (Suppl.), 24 (1980)
4. Multicentre Study Group. Eur. J. Respir. Dis. 61, 93 (1980)
5. McFarlane, J. T., Thorax 40, 832 (1985)
6. Riise, G. C., Larsson, S., Larsson. R. Eur. Respir. J. 94 (1994)
7. National Committee for Clinical Laboratory Standards, Document M11-T2. Villanova. PA (1993)
8. Schmitt, H. J., Bernard, E. M., Hauser, M., Antimicrobial Agents Chemother. 32, 1676 (1988)
9. Marubini, E., Valsecchi, M. G., Analysing survival data from clinical trials and observational studies. Statistics in Practice, p. 91, John Wiley & Sons, New York (1994)
10. Finney, D. J., Probit analysis. Cambridge University Press (1971)
11. Pidoux, J. M., Macciocchi, A., Lacroix, Ch., Med. Hyg. 42, 3421 (1984)
12. Olivieri, D., Marisco, S. A., Del Donno, M., Eur. J. Respir. Dis. 66, 142 (1985)
13. Boman, G., Bäcker, U., Larsson, S., Eur. J. Respir. Dis. 64, 405 (1983)
14. Parr, G. D., Huitson, A., Br. J. Dis. Chest, 81, 341 (1987)
15. Rasmussen, J. B., Glennow, C., Eur. Respir. J., 1, 351 (1998)
16. Andersson, B., Larsson, S., Riise, G., Am. Rev. Respir. Dis., A289 (1991)